Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0000919574-15-002142
Filing Date
2015-02-17
Accepted
2015-02-17 14:42:01
Documents
1

Document Format Files

Seq Description Document Type Size
1 d6367675_13g-a.htm SC 13G/A 117457
  Complete submission text file 0000919574-15-002142.txt   118897
Mailing Address 35 WILBUR STREET LYNBROOK NY 11563
Business Address 35 WILBUR ST LYNBROOK NY 11563 5165937000
BIOSPECIFICS TECHNOLOGIES CORP (Subject) CIK: 0000875622 (see all company filings)

EIN.: 113054851 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-79091 | Film No.: 15621183
SIC: 2834 Pharmaceutical Preparations

Mailing Address 623 FIFTH AVENUE, 31ST FLOOR NEW YORK NY 10022
Business Address 623 FIFTH AVENUE, 31ST FLOOR NEW YORK NY 10022 (212) 231-4932
ARMISTICE CAPITAL, LLC (Filed by) CIK: 0001601086 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A